3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
358
Precursor Cell Lymphoblastic Leukemia-Lymphoma
164
Leukemia
160
Lymphoma
109
Myelodysplastic Syndromes
74
Lymphoma, Non-Hodgkin
66
Lymphoma, Large B-Cell, Diffuse
61
Lymphoma, Mantle-Cell
59
Burkitt Lymphoma
58
Recurrence
56
Congenital Abnormalities
44
Leukemia, Monocytic, Acute
39
Lymphoma, Follicular
37
Hodgkin Disease
35
Leukemia, Myelomonocytic, Acute
34
Leukemia, Erythroblastic, Acute
34
Leukemia, Megakaryoblastic, Acute
32
Blast Crisis
29
Lymphoma, Large-Cell, Immunoblastic
27
Leukemia, Myelomonocytic, Chronic
26
Leukemia, Lymphocytic, Chronic, B-Cell
26
Leukemia, Biphenotypic, Acute
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
24
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, B-Cell, Marginal Zone
19
Anemia, Refractory, with Excess of Blasts
19
Myeloproliferative Disorders
17
Lymphoma, B-Cell
17
Leukemia, Myeloid, Accelerated Phase
16
Neoplasm, Residual
15
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Cytarabine
×
Clear all
NCT00480090
2019-02-15
SLAP
University Health Network, Toronto
Phase 2
Completed
10 enrolled